ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $605,315 | +2.2% | 299,661 | +49.3% | 0.00% | +33.3% |
| Q2 2023 | $592,210 | +7.1% | 200,749 | -9.2% | 0.00% | 0.0% |
| Q1 2023 | $552,695 | -31.0% | 221,078 | -12.5% | 0.00% | -40.0% |
| Q4 2022 | $801,050 | +7.1% | 252,697 | +0.3% | 0.01% | -16.7% |
| Q3 2022 | $748,000 | – | 251,935 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $31,126,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $7,360,000 | 2.65% |
| Logos Global Management LP | 1,010,812 | $18,599,000 | 1.82% |
| S Squared Technology, LLC | 181,220 | $3,334,000 | 1.58% |
| Avidity Partners Management LP | 1,677,845 | $30,872,000 | 0.85% |
| Perceptive Advisors | 3,425,916 | $63,037,000 | 0.80% |
| RTW INVESTMENTS, LP | 2,652,553 | $48,807,000 | 0.76% |
| Sofinnova Investments, Inc. | 509,168 | $9,369,000 | 0.56% |
| HighVista Strategies LLC | 32,062 | $590,000 | 0.44% |
| DAFNA Capital Management LLC | 91,531 | $1,684,000 | 0.40% |